Microbial Fermentation CMO Market Growth

Microbial Fermentation CMO Market Growth is expected at a CAGR of 9.4% Over the Forecast Period | Roots Analysis

According to a recently published report by Roots Analysis, the increasing demand for biopharmaceuticals, technological advancements and cost saving potential of microbial fermentation is driving the demand for services related to microbial manufacturing.

Microbial Fermentation CMO Industry Overview

The microbial fermentation CMO market size was estimated to be worth USD 4.3 billion in 2026 and is expected to reach over USD 9.6 billion by 2035, growing at a CAGR of 9.4% in the forecast period 2026-2035. 

Driven by several blockbuster products and burgeoning pipelines, biologics have become a key focus area for stakeholders in the pharmaceutical industry. Manufacturing of biologics including proteins, peptides, antibodies, enzymes, hormones and growth factors require an adequate expression system. Since the discovery of recombinant DNA technology, several types of microbes have been identified as versatile biomolecule expression systems. This can be attributed to the robustness of these microbial cell lines (as compared to the cells of higher eukaryotes), rendering them as a popular choice for biopharmaceutical manufacturing. Presently, there are several traditional and innovative microbial expression systems / platforms, based on bacteria, fungi and yeast, which are used for manufacturing a variety of conventional and complex biologics, specifically smaller biologics, such as cytokines, growth factors, plasmid DNA, nucleic acids, single-domain antibodies, and non-glycosylated antibody fragments. The aforementioned factors are likely to present lucrative market growth opportunities for contract service providers and the microbial fermentation CMO market is anticipated to grow faster in the coming years.

Browse 140+ figures and 270+ market data tables spread across 365+ pages and detailed Table of Content on “Microbial Fermentation CMO Market by Type of Expression System, Type of Biologic, Company Size, End-user and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035” here: https://www.rootsanalysis.com/reports/microbial-fermentation-cmo-market.html

Market Drivers 

The microbial fermentation CMO market growth is primarily attributed to the advantages offered by the microbial expression systems over other systems, such as cost-effectiveness, high productivity, and the ability to genetically engineer microbes to produce a wide range of pharmaceutical compounds, including antibodies, proteins, peptides, and small molecules. In many cases, microbial fermentation can achieve higher productivities and yields compared to the alternative expression platforms. Additionally, a shift has been observed towards more diverse biopharmaceuticals, as microbial fermentation is well-suited for producing such biologics, including nanobodies, DARPins, and single-chain antibodies. Advancements in microbial engineering, including improvements in genetic engineering, metabolic engineering, and fermentation process development, have further enhanced the capabilities of these systems. Finally, the increased rate of outsourcing microbial fermentation processes to specialized contract development and manufacturing organizations (CDMOs) has contributed to the rise in the use of microbial fermentation in the pharmaceutical industry, as companies leverage their expertise and infrastructure. 

Market Restraints 

The adoption of fermentation is hindered by stringent regulatory compliance for the production and approval of microbial products. Compliance with these regulations require substantial time and financial investment. The complex regulatory pathways can deter new entrants and slow down the introduction of new products in this domain. Further, microbial fermentation requires a steady supply of various high-quality raw materials. Variations in the quality or availability of these materials can affect the fermentation process and the final product, as well. 

Growth Factors

Despite several challenges, various growth factors continue to drive the microbial fermentation CMO market. It is worth noting that several service providers have expanded their service portfolio to include end-to-end microbial fermentation services including fill / finish services and regulatory support. In addition, the microbial fermentation CMO market growth over the next decade is likely to be driven by the increasing popularity of alternative antibodies, such as nanobodies, designed ankyrin repeat proteins (DARPins), and single-chain antibodies, offering superior and more efficient productivity.

Microbial Fermentation CMO Market Segments 

Based on the type of expression system, the market is segmented into Bacterial Expression System, Yeast Expression System and Other Expression Systems

• The bacterial expression system segment led the microbial fermentation CMO market, capturing the largest revenue share of over 65% in 2024.
• The yeast expression system segment is anticipated to show an annual growth rate of 9.1%, during the forecast period.

Based on the type of biologic, the market is segmented into Recombinant Proteins, Enzymes, Plasmid DNA, Antibodies and Other Biologics

• The Recombinant Proteins segment led the microbial fermentation CMO market, capturing the largest revenue share of 45% in 2024.
• The Plasmid DNA segment is anticipated to show an annual growth rate of around 10.5%, during the forecast period.

Based on the company size, the market is segmented into Small Companies, Mid-sized Companies and Large and Very Large Companies

• Large and Very Large Companies led the microbial fermentation CMO market, capturing the largest revenue share of 58.3% in 2024.
• The mid-sized players segment is anticipated to show an annual growth rate of nearly 9%, during the forecast period.

Based on the end-user, the market is segmented into Pharma / Biotech Companies and Academic / Research Institutes

• The pharma / biotech companies are leading the microbial fermentation CMO market, capturing the largest revenue share of 94.6% in 2024.
• In fact, the pharma / biotech companies segment is anticipated to witness the highest market growth rate of 8.8%, annually during the forecast period.

Based on the Key Geographical Regions, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World

• Europe dominated the microbial fermentation CMO market and accounted for the largest revenue share of nearly 47% in 2024.
• In Asia-Pacific, the microbial fermentation CMO market is anticipated to demonstrate lucrative growth of 9.7% during the forecast period.

Key Companies Profiled 

The microbial fermentation CMO market report also includes profiles of key players (listed below) that offer microbial fermentation services:

• AGC Biologics 
• Aldevron 
• BIOVECTRA 
• Eirgenix 
• EtinPro 
• Eurogentec 
• Northway Biotech 

You Can Download Free Sample PDF Copy of This Report At: https://www.rootsanalysis.com/reports/microbial-fermentation-cmo-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com